Anixa Biosciences Inc
(ANIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,028 | -8,306 | -6,026 | -3,213 | -12,698 |
| Depreciation Amortization | -107 | -66 | -61 | -243 | 37 |
| Accounts receivable | 173 | 173 | 173 | 173 | 97 |
| Other Working Capital | 152 | -445 | -363 | -503 | 526 |
| Other Operating Activity | 3,637 | 2,726 | 1,870 | 882 | 4,703 |
| Operating Cash Flow | $-7,173 | $-5,918 | $-4,407 | $-2,904 | $-7,335 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,866 | 4,212 | 5,045 | 2,703 | 4,276 |
| Investing Cash Flow | $4,866 | $4,212 | $5,045 | $2,703 | $4,276 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,280 | 1,930 | 4 | 0 | 3,421 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -6 |
| Other Financing Activity | 0 | 0 | -3 | -17 | 0 |
| Financing Cash Flow | $2,280 | $1,930 | $1 | $-17 | $3,415 |
| Beginning Cash Position | 1,271 | 1,271 | 1,271 | 1,271 | 915 |
| End Cash Position | 1,244 | 1,495 | 1,910 | 1,053 | 1,271 |
| Net Cash Flow | $-27 | $224 | $639 | $-218 | $356 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,173 | -5,918 | -4,407 | -2,904 | -7,335 |
| Free Cash Flow | -7,173 | -5,918 | -4,407 | -2,904 | -7,335 |